Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone and N-acetylcysteine in Hepatic Resections (MENHIR)
NCT01726465Phase 2Terminated
- Sponsor
- Humanitas Research Hospital
- Start
- Nov 2012
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone, acetylcysteine in ischemia-reperfusion injury (IRI), sponsored by Humanitas Research Hospital. Started Nov 2012; status: terminated.
02
Drugs
methylprednisoloneacetylcysteine
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01726465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01726465.